TD Cowen upgraded Clorox (CLX) to Hold from Sell with a price target of $170, up from $155. The company’s fiscal 2025 guidance now appears conservative in light of sequential improvement post the August 2023 cyberattack, the analyst tells investors in research note. The firm says this provides management “with flex to deliver” more earnings “beats-and-raises” while also leaving room for further investment. These factors bode well for Clorox stock in the near-term, contends TD.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLX:
- Clorox price target raised to $171 from $153 at DA Davidson
- Clorox price target raised to $139 from $137 at Barclays
- Clorox CEO: We entered the fiscal year with strong momentum
- Clorox Company Reports Strong Q1 2025 Financial Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
